Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A 68-year-old man presented with sudden onset of unilateral right-sided hearing loss. He stated that this was preceded by several months of constant ringing in his right ear. He had a history of hypertension and type 2 diabetes mellitus that was well controlled with oral hypoglycemic agents. He had no recent head trauma or previous head or neck surgeries. His only medications were atenolol and glyburide. There was no family history of hearing loss. He did not have a history of excess noise exposure or recent travel. No other otolaryngologic symptoms were reported.
On examination, his external ears and tympanic membranes were normal. No middle ear effusions or masses were noted. The Weber tuning fork test lateralized to the left ear. Rinne test was positive in both ears confirming air conduction being louder than bone conduction in both ears. The rest of the head and neck examination including the remainder of his cranial nerve exam was unremarkable.
Complete blood count was normal, and a fluorescent treponemal antibody absorption blood test was negative. The patient received a baseline audiogram demonstrating a high-frequency sensorineural hearing loss (SNHL) in the right ear. Gadolinium-enhanced brain MRI failed to demonstrate any retrocochlear tumor in the internal auditory canal or cerebellopontine angle.
Sudden unilateral SNHL, such as in this vignette, in the absence of a tumor or lesion involving the vestibular nerve, can be attributed to a viral infection in the inner ear. In patients with diabetes or other microvascular risk factors, sudden unilateral sensorineural hearing loss may be attributed to microvascular infarction of the auditory nerve.
The eighth cranial nerve (CN-VIII) is composed of two separate portions: the vestibular and cochlear nerves (vestibulocochlear nerve). The vestibular nerve has efferent and afferent fibers that control balance and equilibrium (see next section). The cochlear nerve, also called the auditory nerve, carries efferent and afferent fibers for hearing. To understand dysfunction of the auditory nerve, a brief description of the human hearing mechanism is required.
Sound waves travel through the external auditory canal and vibrate the tympanic membrane, which in turn produces motion of the middle ear ossicles (malleus, incus, and stapes). The vibrations are transmitted through the oval window at the stapes footplate, causing a fluid wave to travel through the cochlear perilymph. This in turn vibrates the basilar membrane and organ of Corti, stimulating inner and outer hair cells ( Fig. 9.1 ). Hair cells, receptors of the sensorineural system, transmit action potentials to bipolar neurons, the bodies of which are in the spiral ganglion.
Afferent fibers projecting toward the central nervous system (CNS) constitute the auditory nerve ( Fig. 9.2 ). They travel to the dorsal and ventral cochlear nuclei located in the caudolateral pons. Most of the secondary neurons project contralaterally across the midline to the superior olivary nucleus and then travel up the lateral lemniscus into the inferior colliculus of the midbrain. Decussating fibers from the cochlear nucleus to the superior olivary nucleus are located in the trapezoid bodies and also in the base of the pons. Fibers from the inferior colliculus continue to travel rostrally to the medial geniculate body of the thalamus and then terminate in the auditory cortex located in the transverse temporal gyri of Heschl.
Hearing loss can result from pathologic conditions anywhere along the anatomic pathway for hearing. It may spare the auditory nerve, such as in middle ear pathology (e.g., serous otitis media), or involve the auditory nerve (e.g., acoustic tumors). SNHL is a hearing deficit from dysfunction of the cochlea (sensory), the auditory nerve (neural), or any part of the central auditory pathway. Auditory nerve dysfunction usually results in tinnitus, SNHL, or both. A targeted history and physical examination narrow the diagnosis. The temporal profile of symptom onset (i.e., sudden, progressive, fluctuating, or stable) is critical.
Tinnitus presents with or without concomitant SNHL and is classified into two groups. Subjective tinnitus, the most common, is heard solely by the patient. It can range from soft fluctuating ringing noise to loud constant debilitating roar. The cause of subjective tinnitus is usually unknown but is most often associated with SNHL or it can often be associated with exposure to loud noise, ototoxic drugs (such as aspirin, cisplatinum, and aminoglycosides), acoustic tumors, Meniere disease, and cochlear otosclerosis. Objective tinnitus is heard by the patient and the examiner and is usually not a sign of auditory nerve dysfunction. Pulsatile tinnitus is usually secondary to vascular causes, such as arteriovenous malformations or glomus tumors. Middle ear effusions, as in serous otitis media, can magnify vascular pulsations from the nearby internal carotid artery and produce vascular tinnitus. Pulsatile tinnitus may also occur with exposure to CNS pulsations or bone density changes allowing easier transmission of vascular flow sounds through the temporal bone to the cochlea. Clicking tinnitus is secondary to temporomandibular joint disease, palatal myoclonus, or spontaneous contraction of the middle ear muscles.
Determining the laterality of hearing loss is essential. Bilateral deficits occur in processes such as ototoxicity, noise exposure, and hearing loss related to aging (presbycusis). Unilateral hearing loss raises the concern of neoplastic, vascular, neurologic, or infectious etiologies. Fluctuation of hearing is seen in Meniere disease, autoimmune inner ear disease. Progressive SNHL is usually seen with aging or tumors, whereas sudden SNHL occurs with viral neuritis or vascular processes.
Whether the hearing loss involves a process in the external or middle ear versus the inner ear must be determined. An audiogram should be performed on any patient with a complaint of a hearing disorder. The audiogram along with the history and physical examination will then lead to next steps of evaluation or diagnosis by the physician.
Only a few processes, such as otosclerosis and otitic meningitis, involve both the middle ear and the inner ear. Typically, tinnitus and vertigo are inner ear symptoms and indicate involvement of the cochlea, vestibular labyrinth, auditory nerve, or a combination of these structures. However, tinnitus, associated with SNHL, is now known to be a central event, based upon functional MRI studies, much like phantom limb syndrome.
Hearing loss associated with otalgia, otorrhea, headache, and aural fullness is most likely inflammatory and can be confirmed by physical examination. Concomitant tinnitus, vertigo, or both suggest the ominous extension of the inflammatory process to the inner ear or beyond. In this setting, a formal audiogram is indicated to determine whether the perceived hearing loss is secondary to a middle ear effusion or an additional sensorineural component. The latter is an otolaryngologic emergency.
With ototoxicity (aminoglycosides, salicylates, or loop diuretics), migraine headache disorders, and Meniere disease, vestibular symptoms, tinnitus, aural fullness, or a combination of these symptoms may accompany hearing loss. In conditions such as presbycusis and noise-induced hearing loss, vestibular symptoms are less likely to be part of the presentation.
Neurologic or ophthalmologic manifestations accompanying primary otologic symptoms occur with diseases such as multiple sclerosis or expanding neoplastic lesions, which may lead to combined facial nerve, trigeminal nerve, or ophthalmologic symptoms.
Trauma to the temporal bone, resulting in labyrinthine or auditory nerve injury, can result in auditory nerve dysfunction. Diving and flying may cause barotrauma, leading to rupture of the cochlear membranes, with subsequent SNHL. Occupational and recreational noise exposure damages the cochlea's outer hair cells, creating high-frequency SNHL. A family history of hearing loss is important to establish because this can be an important mechanism or predisposing factor for SNHL.
Cerumen impaction or foreign bodies are easily identified on inspection of the external auditory canal. Otoscopic examination allows the physician to inspect the ear canal, tympanic membrane, and middle ear. This is important for identifying various conditions that can contribute to conductive hearing loss. It allows for the identification of fluid in the middle ear, cholesteatoma, or masses. Pneumatic otoscopy is used to assess the mobility of the tympanic membrane.
Tuning fork tests assess whether the hearing loss is conductive or sensorineural ( Fig. 9.3 ). During the head and neck examination, a complete cranial nerve examination must also be performed to assess other potential cranial nerve abnormalities. Facial nerve weakness may be attributed to viral infections, such as herpes zoster oticus, or expanding neoplasms in the internal auditory canal or cerebellopontine angle, such as acoustic neuromas, meningiomas, or facial neuromas. Auscultation of the areas around the orbit and ear may detect objective pulsatile tinnitus. The pattern of SNHL can sometimes assist in the diagnosis of the etiology of hearing loss. The typical pattern for noise-induced SNHL is a drop in the 3–6 kHz frequency range which then improves in higher frequencies. Noise-induced SNHL may also be unilateral if the affected ear is closer to the noise source. Meniere disease and migraine disorders typically manifest with a low-frequency SNHL. Acoustic neuromas typically cause a unilateral SNHL. Speech discrimination significantly worse than would be expected on audiogram results may point to a central auditory processing disorder. Finally, a condition known as auditory neuropathy is manifested by normal auditory brainstem response testing and absence of otoacoustic emissions.
Standard laboratory blood tests are not routinely obtained for hearing loss unless a particular cause is suspected by history and physical examination.
A basic audiogram with pure tones and speech testing determines the type and amount of hearing loss. Unilateral decrease or asymmetries in speech discrimination, SNHL, or acoustic reflex abnormalities suggest a retrocochlear lesion, warranting further investigation.
Gadolinium-enhanced MRI scan of the brain (with particular attention to the internal auditory canals) is specifically indicated when history, symptoms, and audiometric tests strongly suggest retrocochlear disease. MRI is the diagnostic “gold standard” for tumors causing hearing loss. For patients presenting with asymmetric SNHL—especially if sudden—MRI is warranted to exclude acoustic neuromas or other cerebellopontine tumors. MRI may also detect acute and chronic vascular disease or infarction as well as demyelinating lesions.
Brainstem auditory evoked response (BAER) may be a useful objective and quantitative test when a retrocochlear deficit is suspected. It can suggest the site of lesions from the cochlea to the inferior colliculus at the pontine mesencephalic junction. BAER studies were initially considered highly sensitive for retrocochlear causes; however, as with most tests, false-negative and false-positive results are possible. For the purpose of screening for retrocochlear tumors, BAER is not as sensitive as gadolinium-enhanced MRI scans of the brain. The BAER uses electrodes attached to the patient's head and clicking sounds emitted through earphones. The sounds elicit action potentials through the peripheral and central auditory pathways, and the EEG activity is measured and averaged by a computer. Right and left ear waveform morphologic appearance and latencies are compared. Interaural differences suggest pathologic conditions. Five wave peaks characterize the BAER, corresponding to specific anatomic points within the auditory pathway: (1) CN-VIII action potential; (2) cochlear nucleus; (3) olivary complex; (4) lateral lemniscus; and (5) inferior colliculus. A change in peak morphology and latency helps localize the pathologic condition.
This section will briefly discuss some of the more common etiologies of SNHL, such as idiopathic sudden SNHL which is generally defined as greater than 30 dB decline in thresholds over at least three contiguous frequencies, occurring over a period of 72 hours or less.
Meniere disease is an idiopathic condition characterized by a combination of episodic vertigo, fluctuating SNHL, tinnitus, and aural fullness. These episodes typically last hours, and once the episode subsides the symptoms resolve. Over the course of time the hearing loss may become permanent, typically starting in the low-frequency tones before involving the mid- and high-frequency tones. A condition known as “cochlear Meniere disease” typically has the fluctuating hearing loss (maybe tinnitus and fullness) but no vertigo. Meniere disease is often a diagnosis of exclusion, so a full evaluation including MRI scan of the brain with contrast is warranted.
In any case of sudden, unilateral SNHL, neoplastic lesions, although rare, should be considered in the differential until excluded by diagnostic and radiologic testing. Vestibular schwannomas (also known as acoustic neuromas) are benign tumors arising from the Schwann cells of CN-VIII and account for 6% of all intracranial tumors ( Fig. 9.4 ). These occur on the vestibular portion of CN-VIII and involve the adjacent cochlear division by compression against the bony walls of the internal auditory canal. Less commonly, neuromas can also arise directly from the cochlear nerve.
Hearing loss is unilateral and is the most commonly reported symptom, occurring at some point in approximately 95% of patients with vestibular schwannoma. Progressive SNHL generally results from stretching or compression of the cochlear nerve as the tumor grows. In contrast, when hearing loss is precipitous, it is thought to be secondary to occlusion of the internal auditory artery supplying the cochlea. Tinnitus with acoustic neuromas is typically high pitched, continuous, and unilateral. Paradoxically, vestibular symptoms are less frequently reported with vestibular nerve schwannomas because as these lesions grow, the central vestibular system gradually compensates, often limiting any significant or longstanding vestibular symptomatology. Larger tumors occasionally lead to facial or trigeminal nerve involvement with symptoms of facial paralysis or paresthesias, respectively.
Before MRI, BAERs were the diagnostic test of choice for acoustic neuromas, with a sensitivity of 93%–98%. The sensitivity is significantly lower with tumors less than 1 cm (58%). Gadolinium-enhanced MRI scan of the brain (with particular attention to the internal auditory canals) will detect smaller tumors in patients who have had normal BAERs.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here